MENU
ATYR
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

aTyr Pharma (ATYR) Ownership - Who owns aTyr Pharma?

aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform... Show more

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
524.23M
P/E Ratio
N/A
Total Cash
80.35M
Projected Growth
N/A
Total Debt
12.68M
Revenue
N/A
Risk (Beta)
0.84
Dividend Yield
N/A
Total Cash/Share
0.82
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price

Fundamentals

ATYR
Capitalization
524M
P/E Ratio
N/A
Risk (Beta)
0.84
Dividend Yield
N/A
Total Cash
80.3M
Total Cash/Share
0.82
Total Debt
12.7M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
74.8M
P/B Ratio
7.00
Cash Flow
N/A
Earnings
-0.79
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
93K
Current Ratio
5.63
Current Revenue Per Employee
3983.05
Dividends Per Share - Security
N/A
EBITDA
-68.89M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-64.24
Shares Held By Institutions
469M
Shares Outstanding - Current
98M
Total Liabilities
26.9M
Total Volume MTD
N/A
Value
-1
Gain YTD
47.790
View a ticker or compare two or three
ATYR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. ATYR showed earnings on August 07, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details